Research Article
LIN28B Polymorphisms Confer a Higher Postoperative Recurrence Risk in Reproductive-Age Women with Endometrial Polyps
Table 1
Clinical and demographic characteristics of endometrial polyps patients with postoperative recurrence and nonrecurrence.
| Variables | Recurrence, (%) | Nonrecurrence, (%) | a |
| All subjects | 44 (100.0) | 307 (100.0) | | Age, years | | | | <33 | 23 (52.3) | 184 (59.9) | 0.352 | ≥33 | 21 (47.7) | 123 (40.1) | | Menarche age (years) | | | | <13 | 2 (4.5) | 27 (8.8) | 0.506 | ≥13 | 42 (95.5) | 280 (91.2) | | Menstrual cycle (days) | | | | 23-35 | 40 (90.9) | 264 (86.0) | 0.305 | >35 | 4 (9.1) | 43 (14.0) | | Menstrual duration (days) | | | | ≤7 | 33 (75.0) | 277 (90.2) | 0.934 | >7 | 11 (25.0) | 30 (9.8) | | Dysmenorrhea | 6 (13.6) | 61 (19.9) | 0.325 | Abnormal uterine bleeding | 4 (9.1) | 10 (3.3) | 0.151 | Endometritis | 16 (36.4) | 101 (32.8) | 0.648 | Pelvic infection | 2 (4.5) | 7 (2.3) | 0.705 | Salpingitis | 0 (0.0) | 10 (3.3) | 0.465 | Endomotriosis | 1 (2.3) | 5 (1.6) | 0.754 | Intrauterine adhesion | 1 (2.3) | 7 (2.3) | 0.591 | Gravidities | | | | 0 | 16 (36.4) | 126 (41.0) | 0.470 | 1 | 12 (27.3) | 81 (26.4) | | ≥2 | 16 (36.4) | 100 (32.6) | | Abortion | | | | 0 | 28 (63.6) | 208 (67.8) | 0.610 | 1 | 11 (25.0) | 66 (21.5) | | ≥2 | 5 (11.4) | 33 (10.8) | | Deliveries | | | | 0 | 20 (45.5) | 164 (53.4) | 0.429 | 1 | 15 (34.1) | 82 (26.7) | | ≥2 | 9 (20.5) | 61 (19.9) | | Red blood cells (×1012/L) | | | | <4.37 | 23 (52.3) | 156 (50.8) | 0.602 | ≥4.37 | 21 (47.7) | 151 (49.2) | | Hemoglobin (g/L) | | | | <126 | 28 (63.64) | 146 (47.56) | 0.019 | ≥126 | 16 (36.36) | 161 (52.44) | | White blood cells (×109/L) | | | | <6.09 | 25 (56.82) | 150 (48.86) | 0.206 | ≥6.09 | 19 (43.18) | 157 (51.14) | | Number of polyps | | | | Single polyp | 21 (47.73) | 196 (63.84) | 0.059 | Multiple polyps | 23 (52.27) | 111 (36.16) | | Diameter of polyps (cm) | | | | <1.2 | 18 (40.9) | 210 (68.4) | 0.013 | ≥1.2 | 26 (59.1) | 97 (31.6) | | Endometrial thickness (cm) | | | | <0.9 | 22 (50.0) | 153 (49.2) | 0.984 | ≥0.9 | 22 (50.0) | 154 (50.8) | | Average follow-up days | |
|
|
Notes: aChi-square tests or Fisher exact test.
|